Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 52-58

  Barbour, Jason D ^a   Jalbert, Emilie C ^a   Chow, Dominic C ^a   Gangcuangco, Louie Mar A ^a   Norris, Philip J ^b,c   Keating, Sheila M ^b,c   Heitman, John ^b   Nagamine, Lorna ^a   Seto, Todd ^a,e   Ndhlovu, Lishomwa C ^a   Nakamoto, Beau K ^a,d   Hodis, Howard N ^e   Parikh, Nisha I ^a,f   Shikuma, Cecilia M ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STRAUB CLINIC AND HOSPITAL   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f QUEEN S MEDICAL CENTER   (United States)

Author keywords

Biomarker; Cardiovascular disease; Carotid intima media; CD14; CIMT; Cytokines; Framingham risk score; HIV; Monocytes; Regression; Screen; VCAM 1

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE; ANTIVIRAL THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VIRUS LOAD;

BIOMARKER; CARDIOVASCULAR DISEASE; CAROTID INTIMA-MEDIA; CD14; CIMT; CYTOKINES; FRAMINGHAM RISK SCORE; HIV; MONOCYTES; REGRESSION; SCREEN; VCAM-1;

ADULT; ANTIGENS, CD14; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; GPI-LINKED PROTEINS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; RECEPTORS, IGG; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84891612589     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.021     Document Type: Article

References (32)

1. Esser S, Gelbrich G, Brockmeyer N, etal. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol;102:203-13.
2. Hsue PY, Deeks SG, Hunt PW. Immunologic Basis of cardiovascular disease in HIV-infected adults. J Infect Dis;205(Suppl.3):S375-82.
3. Funderburg NT, Zidar DA, Shive C, etal. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood;120:4599-608.
4. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998, 128:262-269.
5. Hsue PY, Scherzer R, Hunt PW, etal. Carotid intima-media thickness progression in HIV-infected adults occurs preferentially at the carotid bifurcation and is predicted by inflammation. J Am Heart Assoc;1.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol inAdults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
7. Brenchley J.M. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Retrovirology 2006, 3(Suppl.1):S98.
8. Feeney ER, McAuley N, O'Halloran JA, etal. The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation. J Infect Dis;207:628-37.
9. Bukrinsky M., Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. JLeukoc Biol 2006, 80:1044-1051.
10. Dube MP, Cadden JJ. Lipid metabolism in treated HIV Infection. Best Pract Res Clin Endocrinol Metab;25:429-42.
11. Feeney ER, Mallon PW. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation. Curr Pharm Des;16:3339-51.
12. Dube M.P., Stein J.H., Aberg J.A., et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003, 37:613-627.
13. Kaplan RC, Sinclair E, Landay AL, etal. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis;217:207-13.
14. Hsue P.Y., Hunt P.W., Sinclair E., et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006, 20:2275-2283.
15. Subramanian S, Tawakol A, Burdo TH, etal. Arterial inflammation in patients with HIV. JAMA;308:379-86.
16. Zawada AM, Rogacev KS, Rotter B, etal. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood;118:e50-61.
17. Rogacev KS, Seiler S, Zawada AM, etal. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J;32:84-92.
18. Sandler NG, Wand H, Roque A, etal. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis;203:780-90.
19. Shikuma CM, Seto T, Liang CY, etal. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses;28:793-97.
20. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007, 147:783-786.
21. Standards of medical care in diabetes-2009. Diabetes Care 2009, 32(Suppl.1):S13-S61.
22. Crawford T.Q., Ndhlovu L.C., Tan A., et al. HIV-1 infection Abrogates CD8+ T cell MAPK signaling responses. J Virol 2011, 85(23):12343-12350.
23. Jalbert E, Shikuma CM, Ndhlovu LC, Barbour JD. Sequential staining improves detection of CCR2 and CX3CR1 on monocytes when simultaneously evaluating CCR5 by multicolor flow cytometry. Cytometry A;83:280-6.
24. Hodis H.N., Mack W.J., Lobo R.A., et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 135:939-953.
25. Hearps AC, Maisa A, Cheng WJ, etal. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS;26:843-53.
26. Berg KE, Ljungcrantz I, Andersson L, etal. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet;5:122-31.
27. Poitou C, Dalmas E, Renovato M, etal. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol;31:2322-30.
28. Baker J., Hullsiek Huppler K., Singh A., et al. Monocyte activation, but not T cell activation, predicts progression of coronary arterial calcium in a contemporary HIV cohort. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, USA 2013, for CDC SUN Study Investigators.
29. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis;206:1558-67.
30. Longenecker C, Funderburg N, Jiang Y, etal. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med.
31. Andresen T.K., Svennevig J.L., Videm V. Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass. Perfusion 2002, 17:15-21.
32. Kaplan RC, Sinclair E, Landay AL, etal. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis;203:452-63.